Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in CATALYST PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 280,889 shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $7M as of 2026-Q1. The position was increased (+0.6% shares). CPRX represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$7M
Current Shares
280,889
Total Value Change
+$3.1M
Total Shares Change
+29,769
Other major holders of CPRX: BNP PARIBAS FINANCIAL MARKETS, CAPITAL FUND MANAGEMENT S.A., BlackRock, Inc.
Increased |
| 280,889 |
+0.6% |
| $7M |
| 0.0% |
| $23.92 |
27 |
| 2025-Q4 | Increased | 279,281 | +0.7% | $6.5M | 0.0% | $23.29 | 27 |
| 2025-Q3 | Decreased | 277,301 | -52.6% | $5.5M | 0.0% | $19.55 | 0 |
| 2025-Q2 | Increased | 585,671 | +11.3% | $12.7M | 0.0% | $21.78 | 31 |
| 2025-Q1 | Increased | 526,297 | +99.4% | $12.8M | 0.0% | $24.69 | 45 |
| 2024-Q4 | Increased | 263,905 | +11.7% | $5.5M | 0.0% | $21.07 | 30 |
| 2024-Q3 | Decreased | 236,222 | -5.9% | $4.7M | 0.0% | $19.56 | 0 |
| 2024-Q2 | Increased | 251,120 | +117.0% | $3.9M | 0.0% | $15.49 | 43 |